Newsroom
Recent Announcements
PhotoPharmics brings renowned experts in Parkinson’s disease and other neurodegenerative diseases to advisory board
Clinical-stage medical device maker PhotoPharmics today announced a Clinical & Scientific Advisory board (CSAB) comprised of six leading experts in Parkinson’s disease (PD) and other neurodegenerative diseases. The board’s aim is to provide clinical and scientific advice and direction to support the PhotoPharmics mission to “Improve the lives of people who suffer from neurodegenerative diseases.”
Featured Article
“Breaking Through the FDA” (Biosphere, 2021)
Innovative medical devices and diagnostics can get to patients and providers sooner under the U.S. Food and Drug Administration’s (FDA) Breakthrough Device Program. The program provides a special regulatory Breakthrough Device Designation for medical products that have the potential to more effectively treat or diagnose serious or life-threatening conditions. See the full article on page 19 >
There's so much to love about our phototherapy device! Be sure to sign up at http://PhotoPharmics.com/connect to stay informed about all our upcoming trials and product information.
49 hours ago ·
2 days ago ·
4 days ago ·
Archived Content